ALFA Finder| Revenue growth | 23.1% YoY for FY26. |
|---|---|
| Margins | Near-term dilution due to expansion; mature centers at 36-37%. |
| Demand visibility | Strong traction in genomics and advanced radiology segments. |
| Management confidence | High, focus on replicating high-margin model in new territories. |
Growth
FY26 Revenue grew 22.5% to INR 3136M; PAT at INR 314M. EBITDA margins at 31.8%.
Outlook
FY27 Revenue guidance ~15%; EBITDA guidance 33%. Capex planned at INR 70cr for 5 hubs and 8 spokes.
Risks
EBITDA margin compression from 33.8% to 31.8% due to high fixed costs of rapid new center expansion.
Earnings Call filed with NSE, NSE: SURAKSHA. Summary written with AI assistance from the document.
Suraksha Diagnostic Ltd: key numbers
- Share price
- ₹357.85
- Market cap
- ₹1,864 Cr
- Revenue (annual)
- ₹310.4 Cr
- Net profit (annual)
- ₹32.19 Cr
- P/E (TTM)
- 44.6×Sector 54.5×
- Promoter holding
- 49.10%+0.00% QoQ
- FII holding
- 13.98%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Suraksha Diagnostic Ltd
All →Suraksha Diagnostic Results Update
Suraksha Diagnostic reported H1 FY27 total income of ₹1,893.09 million and PAT of ₹277.96 million, up 54% year-on-year. The press release accompanies its unaudited quarterly results.
Suraksha Diagnostic Q2 FY27 Results: Net Profit ₹15 Cr, Up 70.5% YoY
Suraksha Diagnostic Ltd reported revenue from operations of ₹99.1 Cr (+25.9% YoY) and net profit of ₹15 Cr (+70.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹15 Cr · +70.5% YoY
Suraksha Diagnostic Board Meeting Date
Suraksha Diagnostic will hold a board meeting on 10 November 2026 to consider September quarter results and other business. Trading window closes from 1 October to 12 November 2026.
Suraksha Diagnostic Other Announcement
Suraksha Diagnostic notified that RTA KFin Technologies is moving its corporate office to Kokapet, Hyderabad from 1 December 2026, with the registered office unchanged. The change is administrative and affects only the RTA's correspondence address.
Suraksha Diagnostic Legal & Regulatory
Suraksha Diagnostic disclosed a one-day delay in shareholding pattern filing, leading to a Rs. 2,360 fine. The Board has noted remedial measures to prevent future recurrence.
Suraksha Diagnostic Management Change
Suraksha Diagnostic has appointed Ms. Shreya Arora as Company Secretary and Compliance Officer, effective October 14, 2026.